These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21174002)
1. Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase. Dunoyer-Geindre S; Fish RJ; Kruithof EK Thromb Haemost; 2011 Mar; 105(3):461-72. PubMed ID: 21174002 [TBL] [Abstract][Full Text] [Related]
2. Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues. Fish RJ; Yang H; Viglino C; Schorer R; Dunoyer-Geindre S; Kruithof EK Biochem J; 2007 Aug; 405(3):597-604. PubMed ID: 17472573 [TBL] [Abstract][Full Text] [Related]
3. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Carlin CM; Peacock AJ; Welsh DJ Am J Respir Cell Mol Biol; 2007 Oct; 37(4):447-56. PubMed ID: 17556673 [TBL] [Abstract][Full Text] [Related]
4. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463 [TBL] [Abstract][Full Text] [Related]
5. Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells. Sekiya A; Morishita E; Maruyama K; Torishima H; Ohtake S J Atheroscler Thromb; 2015 Jul; 22(7):660-8. PubMed ID: 25735397 [TBL] [Abstract][Full Text] [Related]
6. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471 [TBL] [Abstract][Full Text] [Related]
7. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase. Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Haslinger B; Goedde MF; Toet KH; Kooistra T Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961 [TBL] [Abstract][Full Text] [Related]
9. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321 [TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629 [TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Chen JC; Huang KC; Lin WW Cell Signal; 2006 Jan; 18(1):32-9. PubMed ID: 16214041 [TBL] [Abstract][Full Text] [Related]
14. Regulation of anoikis by Cdc42 and Rac1. Cheng TL; Symons M; Jou TS Exp Cell Res; 2004 May; 295(2):497-511. PubMed ID: 15093747 [TBL] [Abstract][Full Text] [Related]
15. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. Liu L; Zhao SP; Zhou HN; Li QZ; Li JX J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915 [TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
17. The effect of fluvastatin on fibrinolytic factors in patients with hypercholesterolemia. Lin TH; Huang CH; Voon WC; Yen HW; Lai HM; Liang HY; Lu YH; Lee KT; Lee CS; Lai WT; Sheu SH Kaohsiung J Med Sci; 2000 Dec; 16(12):600-6. PubMed ID: 11392099 [TBL] [Abstract][Full Text] [Related]
18. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells. Gao P; Wu X; Shui H; Jia R J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573 [TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells. Hu XY; Ma YH; Wang C; Yang YH Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]